Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.9000 (0%) ($40.9000 - $43.5000) on Fri. Mar. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.61% (three month average) | RSI | 49 | Latest Price | $41.9000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -3.305% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-10%) UNG(-5%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.305% (StdDev 6.61%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $42.55 | 5 Day Moving Average | $42.62(-1.69%) | 10 Day Moving Average | $42.96(-2.47%) | 20 Day Moving Average | $42.55(-1.53%) | To recent high | -13.3% | To recent low | 185% | Market Cap | $3.114b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |